326 related articles for article (PubMed ID: 4064843)
1. The labelling index of human and mouse tumours assessed by bromodeoxyuridine staining in vitro and in vivo and flow cytometry.
Wilson GD; McNally NJ; Dunphy E; Kärcher H; Pfragner R
Cytometry; 1985 Nov; 6(6):641-7. PubMed ID: 4064843
[TBL] [Abstract][Full Text] [Related]
2. Cell kinetics in human malignancies studied with in vivo administration of bromodeoxyuridine and flow cytometry.
Riccardi A; Danova M; Wilson G; Ucci G; Dörmer P; Mazzini G; Brugnatelli S; Girino M; McNally NJ; Ascari E
Cancer Res; 1988 Nov; 48(21):6238-45. PubMed ID: 3167869
[TBL] [Abstract][Full Text] [Related]
3. Comparison of BrdUrd and [3H]TdR incorporation to estimate cell proliferation, cell loss, and potential doubling time in tumor xenografts.
Zätterström UK; Johansson M; Källén A; Baldetorp B; Oredsson S; Wennerberg J; Killander D
Cytometry; 1992; 13(8):872-9. PubMed ID: 1459003
[TBL] [Abstract][Full Text] [Related]
4. Kinetic heterogeneity of an experimental tumour revealed by BrdUrd incorporation and mathematical modelling.
Bertuzzi A; Faretta M; Gandolfi A; Sinisgalli C; Starace G; Valoti G; Ubezio P
Bull Math Biol; 2002 Mar; 64(2):355-84. PubMed ID: 11926121
[TBL] [Abstract][Full Text] [Related]
5. Flow cytometric measurement of cell cycle kinetics in rat Walker-256 carcinoma following in vivo and in vitro pulse labelling with bromodeoxyuridine.
Fogt F; Wan J; O'Hara C; Bistrian BR; Blackburn GL; Istfan NW
Cytometry; 1991; 12(1):33-41. PubMed ID: 1825629
[TBL] [Abstract][Full Text] [Related]
6. Double labeling and in vitro versus in vivo incorporation of bromodeoxyuridine in patients with acute nonlymphocytic leukemia.
Raza A; Ucar K; Preisler HD
Cytometry; 1985 Nov; 6(6):633-40. PubMed ID: 3905302
[TBL] [Abstract][Full Text] [Related]
7. Simultaneous triple staining for hypoxia, proliferation, and DNA content in murine tumours.
Webster L; Hodgkiss RJ; Wilson GD
Cytometry; 1995 Dec; 21(4):344-51. PubMed ID: 8608732
[TBL] [Abstract][Full Text] [Related]
8. A comparison between bromodeoxyuridine and 3H thymidine labeling in human breast tumors.
Waldman FM; Chew K; Ljung BM; Goodson W; Hom J; Duarte LA; Smith HS; Mayall B
Mod Pathol; 1991 Nov; 4(6):718-22. PubMed ID: 1724086
[TBL] [Abstract][Full Text] [Related]
9. Cell proliferation and ploidy of human solid tumours: methodological experience with in vivo bromodeoxyuridine and DNA flow cytometry.
Mazzini G; Danova M; Ferrari C; Giordano M; Dionigi P; Riccardi A
Anal Cell Pathol; 1996 Mar; 10(2):101-13. PubMed ID: 8721953
[TBL] [Abstract][Full Text] [Related]
10. Flow cytometric estimation of cell cycle parameters using a monoclonal antibody to bromodeoxyuridine.
Sasaki K; Murakami T; Ogino T; Takahashi M; Kawasaki S
Cytometry; 1986 Jul; 7(4):391-5. PubMed ID: 3089742
[TBL] [Abstract][Full Text] [Related]
11. Cell kinetic studies of in situ human brain tumors with bromodeoxyuridine.
Hoshino T; Nagashima T; Murovic J; Levin EM; Levin VA; Rupp SM
Cytometry; 1985 Nov; 6(6):627-32. PubMed ID: 2998714
[TBL] [Abstract][Full Text] [Related]
12. A method to estimate cell cycle time and growth fraction using bromodeoxyuridine-flow cytometry data from a single sample.
Eidukevicius R; Characiejus D; Janavicius R; Kazlauskaite N; Pasukoniene V; Mauricas M; Den Otter W
BMC Cancer; 2005 Sep; 5():122. PubMed ID: 16176590
[TBL] [Abstract][Full Text] [Related]
13. The use of FITC-conjugated monoclonal antibodies for determination of S-phase cells with fluorescence microscopy.
Gunduz N
Cytometry; 1985 Nov; 6(6):597-601. PubMed ID: 3933924
[TBL] [Abstract][Full Text] [Related]
14. Direct comparison of bromodeoxyuridine and Ki-67 labelling indices in human tumours.
Wilson GD; Saunders MI; Dische S; Daley FM; Robinson BM; Martindale CA; Joiner B; Richman PI
Cell Prolif; 1996 Mar; 29(3):141-52. PubMed ID: 8652743
[TBL] [Abstract][Full Text] [Related]
15. A method to measure the duration of DNA synthesis and the potential doubling time from a single sample.
Begg AC; McNally NJ; Shrieve DC; Kärcher H
Cytometry; 1985 Nov; 6(6):620-6. PubMed ID: 4064842
[TBL] [Abstract][Full Text] [Related]
16. Cell kinetics in mouse epidermis studied by bivariate DNA/bromodeoxyuridine and DNA/keratin flow cytometry.
Kirkhus B; Clausen OP
Cytometry; 1990; 11(2):253-60. PubMed ID: 1690627
[TBL] [Abstract][Full Text] [Related]
17. Specific staining of iododeoxyuridine and bromodeoxyuridine in tumors double labelled in vivo: a cell kinetic analysis.
Pollack A; Terry NH; Wu CS; Wise BM; White RA; Meistrich ML
Cytometry; 1995 May; 20(1):53-61. PubMed ID: 7541331
[TBL] [Abstract][Full Text] [Related]
18. Cell kinetic analysis of murine squamous cell carcinomas: a comparison of single versus double labelling using flow cytometry and immunohistochemistry.
Schultz-Hector S; Begg AC; Hofland I; Kummermehr J; Sund M
Br J Cancer; 1993 Dec; 68(6):1097-103. PubMed ID: 8260360
[TBL] [Abstract][Full Text] [Related]
19. [In-vivo marking of human tumors using BUDR for flow-cytometry determination of kinetic cell parameters].
Kärcher H; McNally NJ; Wilson G; Kärcher KH; Pfragner R
Strahlenther Onkol; 1987 Mar; 163(3):195-200. PubMed ID: 3563881
[TBL] [Abstract][Full Text] [Related]
20. Cell cycle analysis using numerical simulation of bivariate DNA/bromodeoxyuridine distributions.
Yanagisawa M; Dolbeare F; Todoroki T; Gray JW
Cytometry; 1985 Nov; 6(6):550-62. PubMed ID: 4064838
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
